NovaThera

NovaThera was a pioneering regenerative medicine company spun out from Imperial College London, founded by world-renowned scientists Professor Julia Polak and Professor Larry Hench. The company focused on the development of tissue engineering solutions and biomaterials, most notably leveraging its proprietary TheraGlass technology, a bioactive glass platform designed to stimulate natural tissue repair. NovaThera's primary research efforts were directed toward lung tissue engineering, aiming to create bioengineered lung tissue for patients with chronic respiratory conditions such as emphysema and cystic fibrosis. Additionally, the company explored applications in wound care and bone regeneration through various academic and industrial collaborations. Although the company is no longer active, its foundational work significantly influenced the field of regenerative medicine and biomaterials science.